Express News | Avalon GloboCare Announces Launch Of U.S. Sales Of KetoAir Breathalyzer At Hack Your Health By KetoCon 2024 Conference
Moomoo 24/7Apr 22 09:07 ET
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
GlobeNewswireApr 22 09:00 ET
Express News | Avalon GloboCare Shares Are Trading Higher After the Company Announced the Extension of Its Exclusive Distribution Agreement With Qi Diagnostics to Distribute the KetoAir Breathalyzer Device and Related Accessories in North America, South America, the Uni
Moomoo 24/7Mar 28 12:05 ET
Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Globe NewswireMar 28 09:00 ET
Avalon GloboCare Extends Exclusive Distribution Agreement for KetoAir Breathalyzer | NASDAQ:ALBT
Proactive InvestorsMar 28 05:29 ET
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
FREEHOLD, N.J., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
GlobeNewswireDec 18, 2023 09:00 ET
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
BenzingaOct 18, 2023 09:01 ET
It's Probably Less Likely That Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Will See A Huge Pay Rise This Year
Key Insights Avalon GloboCare will host its Annual General Meeting on 12th of October Total pay for CEO David Jin includes US$360.0k salary The total compensation is similar to the average for the
Simply Wall StOct 6, 2023 06:21 ET
Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application
KetoAir Mobile Application Launches in Apple App Store KetoAir Mobile Application also Available in the Google Play Store FREEHOLD, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare
GlobeNewswireOct 4, 2023 09:00 ET
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).The smallest co
BenzingaSep 28, 2023 14:32 ET
Press Release: Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device FREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalo
Dow JonesSep 13, 2023 09:15 ET
Wheeler Real Estate Investment Trust Among Real Estate Gainers, Uniti in Losers
Seeking AlphaSep 7, 2023 12:00 ET
Wheeler REIT Among Real Estate Gainers, Xinyuan in Losers
Seeking AlphaSep 6, 2023 12:11 ET
Reason Why Avalon GloboCare Corp ($ALBT) Surged Today
BioPharma JournalSep 5, 2023 16:57 ET
Top Midday Gainers
Olema Pharmaceuticals (OLMA) unveiled Tuesday a stock purchase agreement for a private placement of about $130 million of its common stock to selected institutional investors. The company also signed
MT NewswiresSep 5, 2023 13:47 ET
CGC, VNDA and TSE Among Mid-day Movers
Seeking AlphaSep 5, 2023 13:07 ET
Hannon Armstrong, Apple Hospitality Among Real Estate Gainers; Safehold in Losers
Seeking AlphaSep 5, 2023 12:01 ET
Avalon GloboCare Shares Soar on Patent Notice
By Dean Seal Shares of Avalon GloboCare rose by a quarter after patent authorities issued a notice of publication for one of the company's patents over receptor proteins. The stock was up 25% at $1.
Dow JonesSep 5, 2023 11:55 ET
Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly With the Massachusetts Institute of Technology (MIT)
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor MoleculesFREEHOLD, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NA
GlobeNewswireSep 5, 2023 08:00 ET
Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis
New Proprietary Testing Method Makes Tuberculosis Diagnosis Easier and Faster New Test Method Expected to Generate Revenue in 2023 FREEHOLD, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp.
GlobeNewswireAug 30, 2023 09:00 ET
No Data
No Data